Drug Shortage Report for TEVETEN PLUS

Last updated on 2019-04-04 History
Report ID 72948
Drug Identification Number 02253631
Brand name TEVETEN PLUS
Common or Proper name TEVETEN PLUS
Company Name BGP PHARMA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROCHLOROTHIAZIDE EPROSARTAN
Strength(s) 12.5MG 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2 x 14CA
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-02-11
Actual start date
Estimated end date 2019-04-15
Actual end date 2019-04-03
Shortage status Resolved
Updated date 2019-04-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2019-04-04 English Compare
v14 2019-04-03 French Compare
v13 2019-04-03 English Compare
v12 2019-03-08 French Compare
v11 2019-03-08 English Compare
v10 2019-02-21 French Compare
v9 2019-02-21 English Compare
v8 2019-02-06 English Compare
v7 2019-01-30 French Compare
v6 2019-01-30 English Compare
v5 2019-01-21 French Compare
v4 2019-01-21 English Compare
v3 2019-01-18 French Compare
v2 2019-01-18 English Compare
v1 2019-01-18 English Compare

Showing 1 to 15 of 15